SCHEMBL8869173

SCHEMBL8869173

COC(=O)CNC(=O)c1ccc(NS(=O)(=O)c2ccc(OCC(F)(F)C(F)(F)C(F)(F)F)cc2)cn1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ LMNA P02545 2/20 0.38
▸ PKM P14618 1/20 0.38
▸ PSEN1 P49768 1/20 0.38
▸ PSEN2 P49810 1/20 0.38
▸ APH1B Q8WW43 1/20 0.38
▸ NCSTN Q92542 1/20 0.38
▸ APH1A Q96BI3 1/20 0.38
▸ PSENEN Q9NZ42 1/20 0.38
▸ EGLN1 Q9GZT9 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869556 0.91 POLB (0.45) POLBKDM4ESMN1; SMN2LMNAPKM
SCHEMBL8869691 0.90 SMN1; SMN2 (0.44) POLBKDM4ESMN1; SMN2LMNAPKM
SCHEMBL8868415 0.89 SMN1; SMN2 (0.38) SMN1; SMN2LMNAPKM
SCHEMBL8869937 0.86 P4HTM (0.52) POLBSMN1; SMN2
SCHEMBL8870073 0.86 SMN1; SMN2 (0.42) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL8869163 0.84 POLB (0.47) POLBLMNAMEN1KMT2AALDH1A1
SCHEMBL8868611 0.82 EGLN1 (0.46) POLBSMN1; SMN2EGLN1
SCHEMBL8867662 0.80 SCN9A (0.48) KDM4ESMN1; SMN2LMNAPKMMEN1
SCHEMBL9574660 0.79 SMN1; SMN2 (0.42) POLBKDM4ESMN1; SMN2LMNAPKM
SCHEMBL8869647 0.79 PGR (0.50) POLBSMN1; SMN2LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 — — US disclosed
Send feedback